​
Login / Signup
Jie-Yoon Kang
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Study Protocol
Randomized Controlled Trial
Cognitive Impairment
Lps Induced
Top Venues
PloS one
Pharmaceuticals (Basel, Switzerland)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Miso S Park
,
Sangsoo Park
,
Jie-Yoon Kang
,
In-Chul Jung
,
Ho-Ryong Yoo
The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
PloS one
19 (5) (2024)
Miso S Park
,
Sangsoo Park
,
Jie-Yoon Kang
,
In-Chul Jung
,
Ho-Ryong Yoo
The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
PloS one
19 (5) (2024)
Miso S Park
,
Sangsoo Park
,
Jie-Yoon Kang
,
In-Chul Jung
,
Ho-Ryong Yoo
The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
PloS one
19 (5) (2024)
Jie-Yoon Kang
,
Jong Suk Lee
,
In-Chan Seol
,
Yoon-Sik Kim
,
Miso S Park
,
Ho-Ryong Yoo
Pharmacological Effects of Gami-Yukmijihwang-Tang on the Lipopolysaccharide-Induced Hippocampus Oxidation and Inflammation via Regulation of Sirt6.
Pharmaceuticals (Basel, Switzerland)
15 (3) (2022)